Latest US Food and Drug Administration Stories
WILMINGTON, Del., Dec. 16, 2010 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for ticagrelor (BRILINTA(TM)).
SAN DIEGO, Dec.
WILMINGTON, Del., Dec.
The US Food and Drug Administration (FDA) has announced a recall of Mylanta and AlternaGel liquid antacids, making it the latest in a long line of Johnson & Johnson affiliated products to face a recall this year.
The US Senate has passed the largest overhaul of the food safety system in more than 70 years Tuesday, in response to massive recalls that have plagued the United States, such as last yearâ€™s recall of more than 500 million eggs after a salmonella outbreak.
A Senate bill set to pass this week would give the US Food and Drug Administration (FDA) the authority to conduct inspections more frequently and order a recall of tainted products.
Kentucky-based Xanodyne Pharmaceuticals has pulled its popular narcotic painkiller, Darvon, from the drug market because it may cause fatal heart rhythms.
SAN DIEGO and WOODCLIFF LAKE, N.J., Oct. 23, 2010 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin.
â€œPink Viagra,â€ an experimental pill claiming to boost a womanâ€™s sex drive, has been scrapped by German maker Boehringer Ingelheim after failing to convince US regulators that the pill actually worked.
US government researchers announced Monday they have combined smallpox and anthrax vaccines into one vaccine, improving them and making them safer, faster-acting and more effective in case of a biological attack.
- A volcanic mudflow.